Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study.

Bonberg N, Pesch B, Behrens T, Johnen G, Taeger D, Gawrych K, Schwentner C, Wellhäußer H, Kluckert M, Leng G, Nasterlack M, Oberlinner C, Stenzl A, Brüning T.

BMC Cancer. 2014 Nov 20;14:854. doi: 10.1186/1471-2407-14-854.

PMID:
25412927
[PubMed - in process]
Free PMC Article
2.

0435 Primary selection and impact of shift work on cardiovascular risk factors.

Yong M, Nasterlack M, Germann C, Pluto RP, Lang S, Oberlinner C.

Occup Environ Med. 2014 Jun;71 Suppl 1:A118. doi: 10.1136/oemed-2014-102362.371.

PMID:
25018229
[PubMed - in process]
3.

A retrospective cohort study of shift work and risk of incident cancer among German male chemical workers.

Yong M, Blettner M, Emrich K, Nasterlack M, Oberlinner C, Hammer GP.

Scand J Work Environ Health. 2014 Sep;40(5):502-10. doi: 10.5271/sjweh.3438. Epub 2014 Jun 3.

PMID:
24892305
[PubMed - in process]
4.

Shift work and risk of non-cancer mortality in a cohort of German male chemical workers.

Yong M, Nasterlack M, Germann C, Lang S, Oberlinner C.

Int Arch Occup Environ Health. 2014 Oct;87(7):763-73. doi: 10.1007/s00420-013-0922-5. Epub 2013 Dec 3.

PMID:
24297469
[PubMed - in process]
5.

Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Pesch B, Taeger D, Johnen G, Gawrych K, Bonberg N, Schwentner C, Wellhäusser H, Kluckert M, Leng G, Nasterlack M, Lotan Y, Stenzl A, Brüning T; UroScreen Study Group.

Int Arch Occup Environ Health. 2014 Oct;87(7):715-24. doi: 10.1007/s00420-013-0916-3. Epub 2013 Oct 16.

PMID:
24129706
[PubMed - in process]
6.

A retrospective cohort study of shift work and risk of cancer-specific mortality in German male chemical workers.

Yong M, Nasterlack M, Messerer P, Oberlinner C, Lang S.

Int Arch Occup Environ Health. 2014 Feb;87(2):175-83. doi: 10.1007/s00420-013-0843-3. Epub 2013 Feb 3.

PMID:
23377535
[PubMed - indexed for MEDLINE]
7.

Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.

Bonberg N, Taeger D, Gawrych K, Johnen G, Banek S, Schwentner C, Sievert KD, Wellhäußer H, Kluckert M, Leng G, Nasterlack M, Stenzl A, Behrens T, Brüning T, Pesch B; UroScreen Study Group.

BJU Int. 2013 Aug;112(4):E372-82. doi: 10.1111/j.1464-410X.2012.11666.x. Epub 2013 Jan 25.

PMID:
23350736
[PubMed - indexed for MEDLINE]
8.

Occupational stress perception and its potential impact on work ability.

Yong M, Nasterlack M, Pluto RP, Lang S, Oberlinner C.

Work. 2013 Jan 1;46(3):347-54. doi: 10.3233/WOR-121556.

PMID:
23324708
[PubMed - indexed for MEDLINE]
9.

Shift work and cancer: state of science and practical consequences.

Yong M, Nasterlack M.

Arh Hig Rada Toksikol. 2012 Jun 1;63(2):153-60. doi: 10.2478/10004-1254-63-2012-2209. Review.

PMID:
22728797
[PubMed - indexed for MEDLINE]
10.

Worker protection during mercury electrolysis cell plant decommissioning.

Besson JC, Augarde E, Nasterlack M.

Arh Hig Rada Toksikol. 2012 Jun 1;63(2):117-22. doi: 10.2478/10004-1254-63-2012-2200.

PMID:
22728793
[PubMed - indexed for MEDLINE]
11.

Analysis of protein adducts as biomarkers of short-term exposure to ethylene oxide and results of follow-up biomonitoring.

Bader M, Will W, Frey G, Nasterlack M.

Arh Hig Rada Toksikol. 2012 Jun 1;63(2):107-15. doi: 10.2478/10004-1254-63-2012-2211.

PMID:
22728792
[PubMed - indexed for MEDLINE]
12.

Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.

Banek S, Schwentner C, Täger D, Pesch B, Nasterlack M, Leng G, Gawrych K, Bonberg N, Johnen G, Kluckert M, Gakis G, Todenhöfer T, Hennenlotter J, Brüning T, Stenzl A; UroScreen Study Group.

Urol Oncol. 2013 Nov;31(8):1656-62. doi: 10.1016/j.urolonc.2012.04.015. Epub 2012 May 22.

PMID:
22621963
[PubMed - indexed for MEDLINE]
13.

Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen.

Johnen G, Gawrych K, Bontrup H, Pesch B, Taeger D, Banek S, Kluckert M, Wellhäußer H, Eberle F, Nasterlack M, Leng G, Stenzl A, Brüning T; UroScreen Study Group.

PLoS One. 2012;7(4):e35363. doi: 10.1371/journal.pone.0035363. Epub 2012 Apr 16.

PMID:
22530010
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.

Huber S, Schwentner C, Taeger D, Pesch B, Nasterlack M, Leng G, Mayer T, Gawrych K, Bonberg N, Pelster M, Johnen G, Bontrup H, Wellhäusser H, Bierfreund HG, Wiens C, Bayer C, Eberle F, Scheuermann B, Kluckert M, Feil G, Brüning T, Stenzl A; UroScreen Study Group.

BJU Int. 2012 Sep;110(5):699-708. doi: 10.1111/j.1464-410X.2011.10883.x. Epub 2012 Feb 7.

PMID:
22313585
[PubMed - indexed for MEDLINE]
15.

Exposure registries: overview and utility for nanomaterial workers.

Schulte PA, Mundt DJ, Nasterlack M, Mulloy KB, Mundt KA.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S42-7. doi: 10.1097/JOM.0b013e31821aebed.

PMID:
21654416
[PubMed - indexed for MEDLINE]
16.

Developing a registry of workers involved in nanotechnology: BASF experiences.

David RM, Nasterlack M, Engel S, Conner PR.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S32-4. doi: 10.1097/JOM.0b013e31821ad73f.

PMID:
21654414
[PubMed - indexed for MEDLINE]
17.

Role of medical surveillance in risk management.

Nasterlack M.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S18-21. doi: 10.1097/JOM.0b013e31821b1d54.

PMID:
21606849
[PubMed - indexed for MEDLINE]
18.

The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.

Pesch B, Nasterlack M, Eberle F, Bonberg N, Taeger D, Leng G, Feil G, Johnen G, Ickstadt K, Kluckert M, Wellhäusser H, Stenzl A, Brüning T; UroScreen Group.

BJU Int. 2011 Aug;108(4):546-52. doi: 10.1111/j.1464-410X.2010.09971.x. Epub 2011 Jan 11. Erratum in: BJU Int. 2011 Oct;108(7):1232.

PMID:
21223477
[PubMed - indexed for MEDLINE]
19.

Is health, measured by work ability index, affected by 12-hour rotating shift schedules?

Yong M, Nasterlack M, Pluto RP, Elmerich K, Karl D, Knauth P.

Chronobiol Int. 2010 Jul;27(5):1135-48. doi: 10.3109/07420528.2010.490111.

PMID:
20636221
[PubMed - indexed for MEDLINE]
20.

Medical program for shift workers--impacts on chronic disease and mortality outcomes.

Oberlinner C, Ott MG, Nasterlack M, Yong M, Messerer P, Zober A, Lang S.

Scand J Work Environ Health. 2009 Jul;35(4):309-18. Epub 2009 May 27.

PMID:
19471844
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk